Elizabeth Fernandez

发表

Glycine supplementation extends lifespan of male and female mice

M. Bogue, D. Vaughan, A. Ryazanov, 2019, Aging cell.

Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy

A. Bokov, R. Strong, J. Gelfond, 2015, Pathobiology of aging & age related diseases.

Rapamycin selectively alters serum chemistry in diabetic mice

B. Kasinath, G. G. Choudhury, K. Sataranatarajan, 2012, Pathobiology of aging & age related diseases.

17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex

N. Rosenthal, L. Leng, R. Bucala, 2021, Aging cell.

Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects

M. Bogue, N. Musi, A. Salmon, 2020, Aging cell.

Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset.

S. Tardif, C. Ross, A. Salmon, 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

Dexamethasone Causes Hypertension in Rats Even Under Chemical Blockade of Peripheral Sympathetic Nerves

A. Soto-Piña, C. Hinojosa-Laborde, C. Rani, 2019, Front. Neurosci..

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset

S. Tardif, C. Ross, A. Salmon, 2019, Pathobiology of aging & age related diseases.

Monoamine metabolism and behavioral responses to ethanol in mitochondrial aldehyde dehydrogenase knockout mice.

G. Gerhardt, W. Koek, R. Strong, 2006, Alcoholism, clinical and experimental research.

San Antonio Nathan Shock Center: your one-stop shop for aging research

N. Musi, A. Salmon, M. Javors, 2021, GeroScience.

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

Marco Pahor, Christy S. Carter, Randy Strong, 2009, Nature.

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

A. Galecki, M. Kaeberlein, E. Verdin, 2022, Aging cell.

Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

Z. D. Sharp, S. Pletcher, A. Salmon, 2014, Aging cell.

Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice.

R. de Cabo, D. Sinclair, B. Teter, 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males

B. Ames, D. Allison, J. Simpkins, 2013, Aging cell.

Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.

R. de Cabo, D. Sinclair, J. Baur, 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease

D. Goldstein, R. Strong, P. Sullivan, 2012, PloS one.

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer

Dudley Lamming, D. Sabatini, J. de Magalhães, 2016, Aging cell.

Canagliflozin extends life span in genetically heterogeneous male but not female mice

D. Allison, N. Rosenthal, A. Galecki, 2020, JCI insight.

Acarbose improves health and lifespan in aging HET3 mice

T. Slaga, J. Wilkinson, G. Lithgow, 2019, Aging cell.

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice

A. Salmon, R. Strong, Yuhong Liu, 2018, Aging.

WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease

W. Koek, G. Marsicano, B. Lutz, 2009, The European journal of neuroscience.

WIN 55 , 212-2 , a Cannabinoid Receptor Agonist , Protects Against Nigrostriatal Cell Loss in the MPTP Mouse Model of Parkinson ’ s Disease

W. Koek, G. Marsicano, B. Lutz, 2011 .

Effects of anabolic androgenic steroids and social subjugation on behavior and neurochemistry in male rats

K. Frahm, R. Strong, A. R. Lumia, 2011, Pharmacology Biochemistry and Behavior.

Rapamycin-induced metabolic defects are reversible in both lean and obese mice

Dudley Lamming, J. Baur, A. Salmon, 2014, Aging.

Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)

S. Tardif, C. Ross, A. Salmon, 2015, Aging.

Canagliflozin Extends Lifespan in Genetically Heterogeneous Male But Not Female Mice

D. Allison, N. Rosenthal, A. Galecki, 2020, bioRxiv.

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease

R. Strong, J. Gelfond, J. Doorn, 2023, Brain and behavior.

Neurochemical and motor changes in mice with combined mutations linked to Parkinson’s disease

R. Strong, Xiang Bai, Elizabeth Fernandez, 2017, Pathobiology of aging & age related diseases.

Interaction of a glucocorticoid‐responsive element with regulatory sequences in the promoter region of the mouse tyrosine hydroxylase gene

É. Fernandez, R. Strong, S. Wang, 2001, Journal of neurochemistry.

Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)

S. Tardif, C. Ross, A. Salmon, 2015, Aging.

Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used

R. Korstanje, G. Cortopassi, R. Allsopp, 2023, GeroScience.